Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001087294-25-000008

Director acquired 254 shares (code L)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jones James Director 2025-09-02 Other acquisition 10b5-1 +12 $3.54 $42 43,950 D
Jones James Director 2025-09-03 Other acquisition 10b5-1 +12 $3.58 $43 43,962 D
Jones James Director 2025-09-04 Other acquisition 10b5-1 +12 $3.60 $43 43,974 D
Jones James Director 2025-09-05 Other acquisition 10b5-1 +12 $3.60 $43 43,986 D
Jones James Director 2025-09-08 Other acquisition 10b5-1 +12 $3.41 $41 43,998 D
Jones James Director 2025-09-09 Other acquisition 10b5-1 +12 $3.43 $41 44,010 D
Jones James Director 2025-09-10 Other acquisition 10b5-1 +12 $3.39 $41 44,022 D
Jones James Director 2025-09-11 Other acquisition 10b5-1 +12 $3.41 $41 44,034 D
Jones James Director 2025-09-12 Other acquisition 10b5-1 +12 $3.54 $42 44,046 D
Jones James Director 2025-09-15 Other acquisition 10b5-1 +12 $3.50 $42 44,058 D
Jones James Director 2025-09-16 Other acquisition 10b5-1 +12 $3.50 $42 44,070 D
Jones James Director 2025-09-17 Other acquisition 10b5-1 +12 $3.38 $41 44,082 D
Jones James Director 2025-09-18 Other acquisition 10b5-1 +12 $3.31 $40 44,094 D
Jones James Director 2025-09-19 Other acquisition 10b5-1 +12 $3.34 $40 44,106 D
Jones James Director 2025-09-22 Other acquisition 10b5-1 +12 $3.29 $39 44,118 D
Jones James Director 2025-09-23 Other acquisition 10b5-1 +12 $3.21 $39 44,130 D
Jones James Director 2025-09-24 Other acquisition 10b5-1 +12 $3.10 $37 44,142 D
Jones James Director 2025-09-25 Other acquisition 10b5-1 +12 $3.10 $37 44,154 D
Jones James Director 2025-09-26 Other acquisition 10b5-1 +12 $3.05 $37 44,166 D
Jones James Director 2025-09-29 Other acquisition 10b5-1 +13 $3.14 $41 44,179 D
Jones James Director 2025-09-30 Other acquisition 10b5-1 +13 $3.12 $41 44,192 D
Loading xslF345X05/wk-form4_1759521732.xml…